Patients often arrive at a first GLP-1 telehealth visit expecting a sales conversation and are surprised to get a medical one. Here is what a competent clinician is actually doing with each part of that intake — and how to use the visit to evaluate them.
Key Takeaways
- A legitimate intake reviews BMI and weight history, medication list, GI and gallbladder history, thyroid cancer family history, mental health, and pregnancy plans.
- Each screening question maps to a specific contraindication or risk — none of it is filler.
- Baseline labs (A1C, lipids, metabolic panel) aren't bureaucracy; they're your before-photo and your safety net.
- If the 'visit' asks less than this, you're not being evaluated — you're being processed.
The History Items and What They Screen For
Weight history and prior attempts
Establishes the clinical indication and pattern — cyclical loss/regain, recent rapid changes that might suggest another condition, and realistic goal-setting.
Medication list
The clinician looks for insulin and sulfonylureas (hypoglycemia risk when combined with GLP-1s), and for drugs where slowed gastric emptying changes absorption timing. This is where thoroughness visibly separates real programs from mills.
GI and gallbladder history
A history of pancreatitis is the classic caution flag requiring individualized judgment. Gallstone history matters because rapid weight loss independently raises gallstone risk — expect a whole article's worth of questions here from a good clinician.
Thyroid cancer family history
GLP-1 labels carry a boxed warning regarding medullary thyroid carcinoma and MEN2 syndrome based on rodent findings. Personal or family history of MTC/MEN2 is a standard contraindication — every legitimate intake asks.
Mental health and eating history
Active eating disorders, and any history of significant depression, warrant real screening — appetite suppression is not neutral in these contexts.
Pregnancy status and plans
GLP-1s are discontinued before conception. A program that doesn't ask isn't doing medicine.
The Labs Question
Best practice is baseline A1C, lipid panel, and comprehensive metabolic panel. Some legitimate async programs accept recent outside labs or order them concurrently rather than requiring them pre-prescription. What separates quality: someone reviews the results and tells you what they mean.
Using the Visit to Grade the Provider
Ask three questions: What's your follow-up schedule? Who do I message when I have side effects, and how fast do they respond? What's your discontinuation plan when I reach goal? Confident, specific answers indicate a real clinical operation.
Programs That Run Real Intakes
Embody
Injectable semaglutide — $149 first month
Physician-supervised injectable semaglutide program with straightforward flat monthly pricing after the intro month.
Compounded medications are not FDA-approved.
Visit Embody Paid linkSesame Care
Brand-name only — Rybelsus and oral Wegovy from $149–$299/mo
Marketplace access to brand-name FDA-approved oral GLP-1s only — no compounded products.
Visit Sesame Care Paid linkCare Bare Rx
Injectable + oral options in intake
Streamlined intake with both injectable and oral compounded pathways depending on clinical review.
Compounded medications are not FDA-approved.
Visit Care Bare Rx Paid linkA thorough intake takes fifteen extra minutes and protects you for the entire course of therapy. Choose the provider that asks more questions, not fewer.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.